EGFR and c-Met-fibronectin type III domain binding molecules

Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making thereof are disclosed. These Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules are useful in the generati...

Full description

Saved in:
Bibliographic Details
Main Authors Jacobs, Steven, Klein, Donna, Diem, Michael, Anderson, Mark, Picha, Kristen, Attar, Ricardo, Moores, Sheri, King, Alastair, Hyun, Linus, O'Neil, Karyn
Format Patent
LanguageEnglish
Published 12.07.2018
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making thereof are disclosed. These Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules are useful in the generation of therapeutic compositions for treating and diagnosing diseases and disorders including cancer.
Bibliography:Application Number: AU20130347952